Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Trump says US needs to own Greenland to deter Russia, China
Kyiv scrambles to repair ruined power grid after Russian attack
Swiss prosecutors summon owners of ski resort bar after deadly blaze
Death toll in Philippines landfill collapse rises to 4
Australian bushfires raze homes, cut power to tens of thousands
